ResearcherUniversity of PittsburghActive in the last 2 years
Jami Lynn Saloman
Matched on ORCID iD 0000-0001-6093-6511; OpenAlex author ID A5086645253; NIH RePORTER profile ID 9176078. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 3
- Labs led
- 1
- Collaborators
- 29
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 grant · 2023: none · 2024: none · 2025: none · 2026: 1 paper, 2 grants
Papers 4
- Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabet… Co-author DOI 10.1097/mpa.0000000000002657↗
- Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001335↗
- Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001090↗
- Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Co-author DOI 10.1073/pnas.1512603113↗
Grants 3
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hanno Steen · 1 shared grant, 2026 · strength 1.26
- Zobeida Cruz‐Monserrate · 2 shared papers, 2019–2026 · strength 0.30
- Paper Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for t… DOI 10.1097/mpa.0000000000002657↗
- Paper Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Can… DOI 10.1097/mpa.0000000000001335↗
- Stephen Jacob Pandol · 2 shared papers, 2019–2026 · strength 0.30
- Paper Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for t… DOI 10.1097/mpa.0000000000002657↗
- Paper Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Can… DOI 10.1097/mpa.0000000000001335↗
- Brian M Davis · 3 shared papers, 2016–2019 · strength 0.24
- Paper Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic … DOI 10.1097/mpa.0000000000001090↗
- Paper Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Can… DOI 10.1097/mpa.0000000000001335↗
- Paper Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of … DOI 10.1073/pnas.1512603113↗
- Temel Tirkes · 1 shared paper, 2026 · strength 0.23
- Mark D. Topazian · 1 shared paper, 2026 · strength 0.23
- Liang Li · 1 shared paper, 2026 · strength 0.23
- Melena D. Bellin · 1 shared paper, 2026 · strength 0.23
- Tonya Palermo · 1 shared paper, 2026 · strength 0.23
- Dhiraj Yadav · 1 shared paper, 2026 · strength 0.23
- Christopher E Forsmark · 1 shared paper, 2026 · strength 0.23
- José Serrano · 1 shared paper, 2026 · strength 0.23
- Darwin Lewis Conwell · 1 shared paper, 2026 · strength 0.23
- Evan L Fogel · 1 shared paper, 2026 · strength 0.23
- Dana K. Andersen · 1 shared paper, 2026 · strength 0.23
- Walter Gwang-Up Park · 1 shared paper, 2026 · strength 0.23
- Phil A. Hart · 1 shared paper, 2026 · strength 0.23
- Santhi Swaroop Vege · 1 shared paper, 2026 · strength 0.23
- Douglas J. Hartman · 2 shared papers, 2016–2018 · strength 0.16
- Paper Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic … DOI 10.1097/mpa.0000000000001090↗
- Paper Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of … DOI 10.1073/pnas.1512603113↗
- Aatur Dilip Singhi · 1 shared paper, 2018 · strength 0.10
- Guy E Groblewski · 1 shared paper, 2019 · strength 0.08
- Fred S. Gorelick · 1 shared paper, 2019 · strength 0.08
- Aliye Uç · 1 shared paper, 2019 · strength 0.08
- Guido Eibl · 1 shared paper, 2019 · strength 0.08
- Mouad Edderkaoui · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.